The global ocular implants market size is anticipated to reach of around US$ 21,700 Mn by 2027 and is anticipated to grow at a CAGR of around 7% in terms of revenue during the forecast period 2020 – 2027.
The eye implant primarily repair the tissue damaged. This is an automated procedure that is used to rehabilitate vision sharpness. Different types of implants for curing eye disease, including intraocular lenses, corneal implants and glaucoma surgery are present in the market. Implants include intraocular lenses, glaucoma implants, corneal implants are used to treat affected or missing eyes. The customized prosthesis eyes are available depend on the dimensions of the eye..
Market Insights
The increasing geriatric population, the rising cases of cataract formation, which is primarily in patients older than 65, is the leading factor to the growth of the ocular implant market. Due to the technological developments in implants such as multifocal intraocular lens technology and rising sensitivity towards esthetics in the younger population the demand in ocular implants will rise significantly in the near future. The factors restraining the development of the market for oculary implants are the lack of qualified specialists in the implantation techniques and the potential side effects of the eye implants.
The global market in eye implants is split into hospitals, eye clinics and specialty-based institutes. The hospital sector is the biggest sectordue to high footfall for such surgeries in hospital end-use setting.. Due to the rising need for eye care facilities in rural areas, specialist eye institutes are projected to be the fastest-growing industry segment.
Report coverage
The market research study on “Ocular Implants Market (By Product Type: Intraocular lenses, Corneal implants, Orbital implants, Glaucoma implants, Ocular prosthesis, Others; By Application: Glaucoma surgery, Oculoplasty, Drug delivery, Age-related macular degeneration, Aesthetic purpose; By End-User: Hospitals, Eye Institutes, Specialty Eye Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027” offers detailed insights on the global ocular implants market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report also provides competitive landscape to understand the current stance of particular player. The report provides insights on global ocular implants market in terms of product type, application, end-users and major geographic regions. The ocular implants market analysis is provided for major regional markets including North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. For each region, the market size for different segments has been covered under the scope of report.
North America accounted for major market share and also dominates the growth of ocular implant market due to increasing number of market vendors to expand their product portfolio in the region. For instance, in July 2018, the San Clemente-based Glaukos, received USFDA approval to deploy the iStent Trabecular Micro-Bypass Program. The new instrument is intended for the diagnosis, along with cataract procedures, of mild to severe primary open-angle glaucomas, which reduces intraocular pressure. The global demand for ocular implants, due to the presence of key players in the region, is expected to fuel growth in Asia Pacific. For instance, in May 2019, innovative therapeutic IOL products and surgical products produced in Italy with a SIFI license were introduced in Indian strategic co-operation by Zydus Cadila. Owing to an growing number of releases in the EU, Europe is projected to see strong growth. Johnson & Johnson Vision, for example, launched TECNIS Eyhance IOL in Europe in February 2019 as suggested for the treatment of cataracts. This intraocular monofocal next generation lens lets patients enjoy high-quality vision at mid and far distances.
Key Players
Major players included in this report Pfizer Inc., Alcon, OSD Medical GmbH, Novartis AG, Staar Surgical, ZEISS International, Bausch & Lomb Incorporated., Johnson & Johnson Services, Inc., Morcher GmbH, Ophtec BV, and others.
The global ocular implants market is segmented as below:
Market Segmentation
Ocular Implants Market By Product Type
- Intraocular lenses
- Corneal implants
- Orbital implants
- Glaucoma implants
- Ocular prosthesis
- Others
Ocular Implants Market By Application
- Glaucoma surgery
- Oculoplasty
- Drug delivery
- Age-related macular degeneration
- Aesthetic purpose
Ocular Implants Market By End-User
- Hospitals
- Eye Institutes
- Specialty Eye Clinics
Ocular Implants Market By Geography
North America
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table Of Content:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Ocular Implants
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Ocular Implants Market By Product Type
1.2.2.1. Global Ocular Implants Market Revenue and Growth Rate Comparison By Product Type (2016-2027)
1.2.2.2. Global Ocular Implants Market Revenue Share By Product Type in 2019
1.2.2.2.1. Intraocular lenses
1.2.2.2.2. Corneal implants
1.2.2.2.3. Orbital implants
1.2.2.2.4. Glaucoma implants
1.2.2.2.5. Ocular prosthesis
1.2.2.2.6. Others
1.2.3. Ocular Implants Market By Application
1.2.3.1. Global Ocular Implants Market Revenue and Growth Rate Comparison By Application (2016-2027)
1.2.3.1.1. Glaucoma surgery
1.2.3.1.2. Oculoplasty
1.2.3.1.3. Drug delivery
1.2.3.1.4. Age-related macular degeneration
1.2.3.1.5. Aesthetic purpose
1.2.4. Ocular Implants Market By End-User
1.2.4.1. Global Ocular Implants Market Revenue and Growth Rate Comparison By End-User (2016-2027)
1.2.4.2. Hospitals
1.2.4.3. Eye Institutes
1.2.4.4. Specialty Eye Clinics
1.2.5. Ocular Implants Market By Geography
1.2.5.1. Global Ocular Implants Market Revenue and Growth Rate Comparison By Geography (2016-2027)
1.2.5.2. North America Ocular Implants Market Revenue and Growth Rate(2016-2027)
1.2.5.3. Europe Ocular Implants Market Revenue and Growth Rate(2016-2027)
1.2.5.4. Asia-Pacific Ocular Implants Market Revenue and Growth Rate(2016-2027)
1.2.5.5. Latin America Ocular Implants Market Revenue and Growth Rate(2016-2027)
1.2.5.6. Middle East and Africa (MEA)Ocular Implants Market Revenue and Growth Rate(2016-2027)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Ocular Implants Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Ocular Implants Major Manufacturers in 2019
3.3. R&D Status and Technology Source of Global Ocular Implants Major Manufacturers in 2019
3.4. Raw Materials Sources Analysis of Global Ocular Implants Major Manufacturers in 2019
CHAPTER 4. OCULAR IMPLANTS MARKET BY PRODUCT TYPE
4.1. Global Ocular Implants Revenue By Product Type
4.2. Intraocular lenses
4.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.3. Corneal implants
4.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.4. Orbital implants
4.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.5. Glaucoma implants
4.5.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.6. Ocular prosthesis
4.6.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.7. Others
4.7.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 5. OCULAR IMPLANTS MARKET BY APPLICATION
5.1. Global Ocular Implants Revenue By Application
5.2. Glaucoma surgery
5.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.3. Oculoplasty
5.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.4. Drug delivery
5.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.5. Age-related macular degeneration
5.5.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.6. Aesthetic purpose
5.6.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 6. OCULAR IMPLANTS MARKET BY END-USER
6.1. Global Ocular Implants Revenue By End-User
6.2. Hospitals
6.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.3. Eye Institutes
6.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.4. Specialty Eye Clinics
6.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 7. NORTH AMERICA OCULAR IMPLANTS MARKET BY COUNTRY
7.1. North America Ocular Implants Market Revenue and Growth Rate, 2016 - 2027 ($Million)
7.2. North America Ocular Implants Market Revenue Share Comparison, 2016 & 2027 (%)
7.3. U.S.
7.3.1. U.S. Ocular Implants Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
7.3.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
7.4.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 8. EUROPE OCULAR IMPLANTS MARKET BY COUNTRY
8.1. Europe Ocular Implants Market Revenue and Growth Rate, 2016 - 2027 ($Million)
8.2. Europe Ocular Implants Market Revenue Share Comparison, 2016 & 2027 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.3.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.4.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.5.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.6.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.7.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 9. ASIA-PACIFIC OCULAR IMPLANTS MARKET BY COUNTRY
9.1. Asia-Pacific Ocular Implants Market Revenue and Growth Rate, 2016 - 2027 ($Million)
9.2. Asia-Pacific Ocular Implants Market Revenue Share Comparison, 2016 & 2027 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.3.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.4.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.5.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.6.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.7.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.8.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 10. LATIN AMERICA OCULAR IMPLANTS MARKET BY COUNTRY
10.1. Latin America Ocular Implants Market Revenue and Growth Rate, 2016 - 2027 ($Million)
10.2. Latin America Ocular Implants Market Revenue Share Comparison, 2016 & 2027 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.3.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.4.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.5.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 11. MIDDLE EAST & AFRICA OCULAR IMPLANTS MARKET BY COUNTRY
11.1. Middle East & AFRICA Ocular Implants Market Revenue and Growth Rate, 2016 - 2027 ($Million)
11.2. Middle East & AFRICA Ocular Implants Market Revenue Share Comparison, 2016 & 2027 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
11.3.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
11.4.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
11.5. Rest of Middle East & AFRICA
11.5.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
11.5.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 12. COMPANY PROFILE
12.1. Pfizer Inc
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Type Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Alcon
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Type Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. OSD Medical GmbH
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Type Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Novartis AG
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Type Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Staar Surgical
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Type Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. ZEISS International
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Type Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Bausch & Lomb Incorporated
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Type Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Johnson & Johnson Services, Inc
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Type Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Morcher GmbH
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Type Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Ophtec BV
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Type Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Others
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Type Portfolio
12.11.5. Key Developments
12.11.6. Strategies
CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
